GlassScriptPhysician profile
Ilija Aleksic
NPI 1962820977
$28,053.61
in general payments reported to CMS, 2019-2025
48 companies · $12K in 2025
The $12K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,916 · 2020: $297 · 2021: $725 · 2022: $1,728 · 2023: $3,703 · 2024: $7,106 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,620 · Consulting Fee: $9,444 · Travel and Lodging: $3,289 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,619.50 |
| Consulting Fee | $9,444.00 |
| Travel and Lodging | $3,289.38 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $6,620.88 | 2019-2025 | Coloplast Tfl Drive, Titan, Porges Coloplast |
| Bioprotect Medical, INC. | $6,190.96 | 2025 | Bioprotect Balloon Implant System |
| Ferring Pharmaceuticals INC. | $2,337.31 | 2019-2025 | Adstiladrin |
| Telix Pharmaceuticals | $2,007.93 | 2023-2025 | Illuccix |
| Boston Scientific Corporation | $1,622.03 | 2022-2025 | Tactra, Ams 700 Cxr Rte Kit, Lithovue |
| Janssen Biotech, INC. | $1,216.92 | 2021-2025 | Erleada, Akeega |
| Teleflex LLC | $837.79 | 2022-2025 | Urolift, Barrigel |
| Axonics, INC. | $699.27 | 2023-2024 | Bulkamid, Axonics |
| Novartis Pharmaceuticals Corporation | $668.94 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $614.23 | 2021-2025 | Prolaris |
| Astellas Pharma US INC | $586.77 | 2019-2024 | Myrbetriq, Xtandi |
| Urogen Pharma, INC. | $478.60 | 2021-2025 | Jelmyto |
| Palette Life Sciences, INC. | $377.41 | 2021-2023 | |
| Calyxo, INC. | $342.22 | 2024-2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $324.72 | 2020-2025 | Keytruda, Lynparza |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilija Aleksic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.